[Anakinra in the treatment of rheumatoid arthritis].
Loft
Anne Gitte Rasmussen
AG
Medicinsk Afdeling, Vejle Sygehus, DK-7100 Vejle. agloft2000@yahoo.dk
Tarp
Ulrik
U
Thomsen
Bjarne Svalgaard
BS
D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D000075202:Contraindications; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein; D016032:Randomized Controlled Trials as Topic; D012795:Sialoglycoproteins / Q000009:adverse effects / Q000627:therapeutic use*
D018501:Antirheumatic Agents; C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D012795:Sialoglycoproteins